ChartMill assigns a Buy % Consensus number of 83% to HTGM. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-04-19 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-03 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-01-07 | Craig-Hallum | Upgrade | Hold -> Buy |
| 2021-05-14 | SVB Leerink | Maintains | Outperform |
| 2021-05-14 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-26 | HC Wainwright & Co. | Maintains | Buy |
7 analysts have analysed HTGM and the average price target is 6.12 USD. This implies a price increase of 1175% is expected in the next year compared to the current price of 0.48.
The consensus rating for HTG MOLECULAR DIAGNOSTICS (HTGM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.